BackNanoViricides Overview

NanoViricides Intangible Assets

Latest intangible assets for NNVC: $310B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$310.84B
↑ 97408284.67% YoYΔ $310.84B vs prior year quarter

Peer trimmed avg / median

Loading

NanoViricides Intangible Assets History

Loading

NanoViricides vs. peers: Intangible Assets Comparison

Loading

NanoViricides Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NanoViricides (NNVC) FAQ

As of the most recent data (March 2026), NNVC shows a intangible assets of $310B. That compares with $320K in the prior-year period — up 97408284.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NNVC's intangible assets is now $310B (was $320K) — a 97408284.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NanoViricides is outperforming or lagging.

Tracking NNVC's intangible assets over time shows whether NanoViricides is scaling, shrinking, or reshaping that part of the business. The current reading is $310B That compares with $320K in the prior-year period — up 97408284.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has NanoViricides's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $310B) with ownership activity and broader fundamentals.

NanoViricides's intangible assets is $310B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.